Related Experiment Video
Updated: Dec 10, 2025
09:29
Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Published on: October 29, 2015
30.7K
Entry Inhibitors: Efficient Means to Block Viral Infection
Gourab Prasad Pattnaik1, Hirak Chakraborty2,3
1School of Chemistry, Sambalpur University, Jyoti Vihar, Burla, Odisha, 768 019, India.
The Journal of Membrane Biology
|August 31, 2020
Summary
Viral entry inhibitors, including peptides and small molecules, offer a promising strategy against emerging infectious diseases. This review highlights their potential for broad-spectrum antiviral activity, moving beyond single-target approaches.
Area of Science:
- Virology
- Drug Discovery
- Immunology
Background:
- Emerging and re-emerging viral infections pose significant global health threats.
- Current vaccine development often focuses on neutralizing viral fusion proteins with antibodies.
- The COVID-19 pandemic underscores the need for broader antiviral strategies beyond the 'one bug-one drug' model.
Purpose of the Study:
- To review peptide and small molecule-based entry inhibitors targeting viral entry mechanisms.
- To explore the potential of these inhibitors as broad-spectrum antiviral agents.
- To discuss inhibitors effective against Class I, II, and III viruses.
Main Methods:
- Literature review of scientific publications on viral entry inhibitors.
- Analysis of studies focusing on peptides and small molecules that block virus-host cell fusion.
- Categorization of inhibitors based on viral class (I, II, III).
Main Results:
- Peptide and small molecule entry inhibitors are effective in blocking viral entry, a critical step in infection.
- These inhibitors demonstrate high selectivity for specific viruses, similar to antibody-based vaccines.
- The review identifies various entry inhibitors with potential for broad-spectrum antiviral applications.
Conclusions:
- Viral entry inhibitors represent a crucial therapeutic strategy, particularly for combating viral infections.
- Shifting focus towards broad-spectrum antiviral agents is essential in light of recent pandemics.
- Peptide and small molecule entry inhibitors hold significant promise for developing next-generation antiviral therapies.
Related Concept Videos
01:29Immune Response Against Viral Pathogens
1.5K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.5K
01:30Enzyme Inhibition
89.7K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
89.7K
01:29Viruses with RNA Genomes
522
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
522
01:28Introduction to Virus
886
Viruses are unique biological entities that blur the boundary between living and non-living systems. Although they lack cellular structure and metabolic processes, they can exhibit characteristics of life when infecting a host. Their defining feature is a nucleic acid core, composed of either DNA or RNA, encapsulated within a protein coat called a capsid. This simple structure allows them to invade host cells and use their machinery for replication efficiently.Viral Structure and...
886
01:52Eukaryotic Transcription Inhibitors
10.7K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.7K
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
123
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
123